Angiopoietin-like-4 (ANGPTL4) is reported to mediate proteinuria in some types of 3 glomerulonephropathy. However, the mechanism underlying the effect on podocytes of 4 ANGPTL4 under pathologic conditions in diabetic nephropathy (DN) is unclear. We 5 investigated the role of ANGPTL4 in the pathogenesis of DN. In DN rats, elevated 6
Diabetic nephropathy (DN), a complication of diabetes, is the major cause of end-stage 25 renal failure worldwide. Proteinuria is the hallmark of DN, and the glomerulus has become 26 the focus of research on the mechanism of proteinuria. The progressive dysfunction and/or 27 loss of podocytes play central roles in proteinuria and kidney dysfunction and have attracted 28 intense scientific attention. Recent studies have explored several circulating or 29 podocyte-secreted proteins, such as serum-soluble urokinase receptor(Wei, El Hindi, Li et al., 30 2011), vascular endothelial growth factor (Sison, Eremina, Baelde et al., 2010), and 31 angiopoietin-like-4 (ANGPTL4)(Clement, Avila-Casado, Mace et al., 2011), which mediate 32 damage to the glomerular filtration barrier, likely in an autocrine or paracrine manner. 33 ANGPTL4 is a secreted glycoprotein belonging to the angiopoietin-like protein family 34 (eight members, Angptl1-8), which shares some structural similarities with angiopoietins. 35 Functionally, it is implicated in the pathogenesis of hypertriglyceridemia(Clement, Mace, 36 Avila-Casado et al., 2014), redox regulation (Zhu, Tan, Huang et al., 2011), wound 37 repair(Chong, Chan, Goh et al., 2014), cardiovascular diseases(Smart-Halajko, Robciuc, 38 Cooper et al., 2010), and tumor metastasis (Tanaka, Irie, Yamamoto et al., 2015) . 39 Glomerular ANGPTL4 secreted by podocytes is upregulated in certain podocyte-related 40 diseases, such as experimental minimal change disease and membranous nephropathy, and 41 podocyte-specific ANGPTL4-transgenic rats exhibit considerable proteinuria(Clement et al., 42 2011,Li, Chen, Peng et al., 2015) . Moreover, increased glomerular and urinary ANGPTL4 43 expression has been identified in diabetic rats (Ma, Chen, Li et al., 2015). Hence, glomerular 44 ANGPTL4 may mediate proteinuria in some types of glomerulonephropathy. However, the 45 mechanism underlying the effects of ANGPTL4 on podocyte function under pathologic 46 conditions are unclear. 47 ANGPTL4 disrupts intercellular adhesion via the integrin-mediated Rac/PAK signaling 48 pathway in human microvascular endothelial cells (Huang, Teo, Chong et al., 2011). In 49 podocytes, activation of integrin β3 promotes the effacement of podocyte foot processes (Wei 50 et al., 2011), and α3 and β1 integrin podocyte-specific knockout mice develop proteinuria 51 (Pozzi, Jarad, Moeckel et al., 2008). However, whether increased expression of ANGPTL4 in 52 DN is mediated by integrin signaling and affects podocyte cytoskeleton and function is 53 unclear. 1 We investigated the role and the underlying mechanism of ANGPTL4 in the 2 pathogenesis of DN by conducting pathological, cellular, and molecular analyses. Our 3 findings show that ANGPTL4 modulates proteinuria by interacting with and activating 4 integrin signals, thus affecting the podocyte cytoskeleton. 5 6 2. Materials and methods 7 8 2.1. Animal studies 9 10
The study was approved by the animal care committee of Shanghai Jiao Tong University 11 Affiliated Sixth People's Hospital and complied with the Institutional Animal Care and Use 12
Committee (IACUC). Male Sprague-Dawley (SD, 8 weeks old) rats were obtained from 13 Shanghai SiLaike (SLAC) Laboratory Animal Company (Shanghai, China). Rats were given 14 free access to food and water, and were maintained under a 12/12 h light-dark cycle with 15 controlled temperature (22± 2 °C) and humidity (50 ±10%). Ten rats were fed with chow as 16 control group. Another ten rats were fed with high fat diet. After one month, those ten SD rats 17 fed with high fat diet were administered an intraperitoneal injection of streptozotocin (STZ, 18 30 mg/kg body weight; Sigma, St. Louis, MO) in 0.05 mol/l citrate buffer (pH 4.4) to induce 19 diabetes mellitus (DM). The control rats were injected with the citrate buffer alone. Only the 20 rats with glucose levels higher than 16.7 mmol/l 7 days after STZ injection were included in 21 the study. Blood samples were collected and serum was prepared, and tissues were 22 immediately excised. Samples were collected at the same time from a group of control rats, 23 which did not receive the STZ injection and were therefore non-diabetic. 24 Male C57BLKS/J-lepr db /lepr db mice (db/db mice) were used as a DN model and age-and 25 sex-matched wild type mice as controls (WT mice). All mice were purchased from the Model 26
Animal Research Center of Nanjing University in China. Mice were given free access to food 27 and water, and were maintained under a 12/12 h light-dark cycle with controlled temperature 28 (22± 2 °C) and humidity (50 ±10% harvested, minced into small pieces, and digested with collagenase A (Roche), and filtered 42 through a cell strainer, washed with HBSS buffer, then subjected to magnetic particle 43 isolation. For rat, glomeruli were isolated by a differential sieving method as previously 44 described(Zhang, Ren, Yang et al., 2016).The renal cortex was separated and successively 45 passed through three stainless steel sieves with pore sizes of 177 (80 mesh), 125 (120 mesh), 46 and 74µm (200 mesh). D-Hank's buffer containing vanadate (phosphatase inhibitor) was used 47 for the continuous rinsing of debris. Glomeruli collected on the last sieve were harvested and 48 used for Western blotting analysis. 49 2.3. Urine analysis 50 51
Timed (12-hour) urine collection was collected from each rat and mouse in individual 52 metabolic cage and centrifuged at 2,000g for 5 min and the animal were sacrificed. Urinary 53 albumin concentrations were measured using a mouse albumin ELISA kit (AKRAL-121; 54 Shibayagi, Gunma, Japan)(Maki, Maeda, Sonoda et al., 2017). Urinary creatinine 55 concentration was measured on a Hitachi 7600 analyzer using the sarcosine oxidase PAP 1 method. The urinary albumin:creatinine ratio (UACR)was computed and is reported in 2 milligrams per gram (mg/g; 1 mg/g = 0.131 mg/mmol). 3 4 2.4. Histopathological Analysis and Immunohistochemistry 5 6
For light microscopy, kidney sections were immersed in 10% formalin and embedded in 7 paraffin. Kidney sections were stained with periodic acid-Schiff (PAS) reagent for the 8 measurement of mesangial expansion and glomerulosclerotic injury. Histopathological 9 analysis were scored in a blinded fashion and mesangial expansion was defined as periodic 10 acid-Schiff-positive and nuclei-free area in the mesangium ( podocyte was scored on a scale ranging from one to four on the basis of the ratio of the 27 deranged area (score=1, 0%-25%; score=2, 25%-50%; score=3, 50%-75%; score=4, 28 75%-100%) in a blinded manner by three independent investigators. At least 20 cells in 5 29 randomly chosen high-power fields were tested, and the mean scores for the deranged area in 30 those cells were calculated. 31 32 2.6. Electron Microscopy 33 34
For electron microscopic examination, kidney cortical tissues were cut into small 35 pieces(1 mm 3 ) , fixed in 2.5% glutaraldehyde solution in phosphate buffer (pH 7.4), postfixed 36 with 1% osmium tetroxide, dehydrated, and embedded in Epon 812. Ultrathin sections were 37 stained with uranyl acetate and lead citrate and then examined with an electron microscope. 38 The quantification of podocyte effacement was performed as previously described (Mallipattu 39 et al., 2014). In brief, negatives were digitized, and images with a final magnitude of 40 approximately at ×5,000 and ×15,000 were obtained. ImageJ was used to measure the length 41 of the peripheral glomerular basement membrane (GBM), and the number of slit pores 42 overlying this GBM length was counted. The arithmetic mean of the foot process width (W FP ) 43 was calculated using the following equation: 44
where ∑GBM length indicates the total GBM length measured in oneglomerulus, ∑slits 46 indicates the total number of slits counted, and is the correction factor for the random 47 orientation by which the footprocesses were sectioned. 48 49 2.7. Apoptosis detection 50 51
Apoptotic morphology of cells was assessed using Hoechst 33258 staining. Cells were 52 stained according to the manufacturer's instructions (Sigma-Aldrich). Uniformly blue stained 53 nuclei were scored as healthy, viable cells, whereas condensed or fragmented nuclei that 54 stained blue were counted as apoptotic. At the end of culture experiments, podocytes were 1 fixed overnight at 4 ℃, permeabilized and stained for 5 min in the dark at room temperature 2 with Hoechst 33258 diluted 1:200 from a 1 mg/mL stock solution. Morphology was examined 3 under a fluorescence microscope at an excitation wavelength of 350 nm (Axio Scope.A1, Carl 4
Zeiss, Germany). Moreover, immunohistochemistry for cleaved caspase-3 was performed to 5 determine the apoptosis of glomerular cells in each group of mice. 6 7 2.8. Cell Culture 8 9 The conditionally immortalized human podocyte cell line was kindly provided by Dr. 10 John Cijiang He (Icahn School of Medicine at Mount Sinai, New York, USA.), and the cells 11 were cultured as previously described (Fan, Xiao, Li et al., 2015). Cells were grown in 12 RPMI-1,640 medium supplemented with 10% fetal bovine serum and 1% 13 penicillin-streptomycin antibiotics. Cells were cultured on rat tail collagen-I-coated plates 14 and maintained at 33℃(5% CO2, 90% humidity). Before experiments, cells were moved to a 15 37 ℃ incubator and cultured for at least 7 days to fully induce differentiation. All 16 experiments were performed with differentiated podocytes. HG culture media was made by 17 supplementing normal glucose (NG) culture media (RPMI 1640 media containing 18 5.5mMD-glucose) with additional D-glucose for a final D-glucose concentration at 30 mM. 19 Podocytes cultured in 5.6mMD-glucose supplemented with 24.4mM D-mannitol to maintain 20 constant isotonicity or osmolality were used as isotonic control. 21 Podocytes were made quiescent by serum-free medium for 24 h before treatment. Cells were 22 treated with recombinant full-length ANGPTL4 protein(100ng/ml) was obtained from R&D 23
Systems. Anti-ANGPTL4 neutralizing antibody (10μg/ml) and ManNAc (1mg/ml) were 24 used to observe its effect on high glucose-induced podocyte injury. 25 26 27
2.9. Lentivirus-mediated downregulation of human integrin β1. 28 29 For lentivirus packaging, the pLKO vectors encoding shRNA specific to the integrin β1 30 gene and the scramble shRNA lentiviral particle were transfected into HEK293T cells with 31 lentiviral packaging plasmid psPAX2 and envelope plasmid pMD2.G using Lipofectamine 32
2000 Reagent (Invitrogen) according to the manufacturer's recommendations. For 33 transduction of podocytes, cells were incubated with viral supernatants supplemented with 34 8µg/ml polybrene were incubated for 24 hours, followed by puromycin selection (1 µg ml −1 ) 35 for additional 72 hours prior to use in all studies. angiopoietin-like-4 antibody(ab196746, abcam).Isolated glomerulus lysates from Kidney 49 cortex or cultured podocytes were lysed in lysis buffer with a sonicator and centrifuged at 12 50 000 × g for 10 min at 4 °C. In all, 30 µg of total protein samples were separated by 8-12% gel 51 electrophoresis and electrotransferred onto polyvinylidene difluoride membranes (Merk 52
Millipore, Billerica, MA, USA).Membranes were initially blocked (TBS, 0.1% Tween 20 and 53 5% nonfat dry milk) for 1 hour and incubated with primary antibodies overnight at 4 °C and 1 then incubated with the appropriate horseradish peroxidase-conjugated secondary antibody. 2 Immunoreactions were visualized with Amersham ECL Plus Western Blotting Detection 3
Reagents (GE Healthcare). The resulting bands were quantified by densitometry. 4 5 2.11. Statistical analysis 6 7
The data are expressed as mean ± SEMs. One way ANOVA followed by Bonferroni 8 correction was used to analyze means between more than two groups. Unpaired t test was 9 used to analyze data when two groups were present. GraphPad Prism software was used for 10 statistical analyses. All experiments were repeated at least 3 times, and representative 11 experiments are shown. Data were considered statistically significant when P < 0.05. 12 13 3. Results 14
ANGPTL4 Expression is Upregulated in the Glomerulus of Diabetic Rats and in High 15
Glucose-Induced Immortalized Human Podocytes (Fig. 1 ) 16 17 Compared to controls, diabetic rats had significantly higher mRNA and protein levels of 18 ANGPTL4 in glomeruli, proteinuria levels, kidney/body weight ratios, glomerular fibronectin 19 (FN) levels (indicating a significant increase in the amount of extracellular matrix), amounts 20 of glomerular extracellular matrix, and podocyte foot process effacement and glomerular 21 basement membrane (GBM) thickening (major early ultrastructural changes observed in DN). 22 In addition, in vitro, the mRNA and protein levels of ANGPTL4 in podocytes were 23 significantly higher under the high-glucose (HG; 30 mM) condition compared to the normal 24 glucose (NG; 5.6 mM; control) condition. 25 26
Increased ANGPTL4 Expression is Associated with Hyperglycemia-Induced Apoptosis 27
and Actin Cytoskeleton Derangement 28 29
Dysfunction of podocytes plays a critical role in the development of DN. We determined 30 the effects of ANGPTL4 on apoptosis and the actin cytoskeleton of podocytes under HG 31 conditions. Western blotting showed that cleaved caspase-3 levels were significantly 32 increased under HG conditions and by treatment with recombinant ANGPTL4 compared to 33 controls and was attenuated by an anti-ANGPTL4 neutralizing antibody ( Fig. 2A-2B ). 34 Moreover, anti-ANGPTL4 antibody can also reduce ANGPTL4-induced apoptosis under 35 normoglycemic conditions, and ANGPTL4 itself does not cause increased podocyte apoptosis 36 (Supplementary- Fig. 1 ). Hoechst staining showed that the number of apoptotic podocytes was 37 significantly increased under HG compared to controls ( Fig. 2C-2D ). Importantly, ANGPTL4 38 alone induced apoptosis of podocytes. Furthermore, HG-induced apoptosis of podocytes was 39 attenuated by an anti-ANGPTL4 antibody ( Fig. 2C-2D incubated under HG conditions showed similar effects ( Fig. 2E-2F ). Thus, HG-induced 49 cytoskeletal derangement in podocytes may be due to an increase in ANGPTL4 expression. 50 Interestingly, the above responses were prevented by an anti-ANGPTL4 antibody. These data 51
suggest that ANGPTL4 plays an important role in podocyte dysfunction under HG conditions. 52 53
ANGPTL4 Induces Podocytes Apoptosis and Actin Cytoskeleton Derangement via the 54
Integrin-β1/FAK Pathway under High-Glucose Conditions 55 1 Next, we identified the mechanism by which ANGPTL4 induces podocyte apoptosis and 2 actin cytoskeletal derangement under HG conditions. We showed that ANGPTL4 increased 3 FAK and ERK (an integrin-signaling protein) phosphorylation under HG conditions; 4 intriguingly, HG resulted in increased β1-integrin expression ( Fig. 3A) . These data suggest 5 that the integrin-β1/FAK pathway plays a role in ANGPTL4-induced apoptosis of podocytes 6 under HG conditions. 7 We hypothesized that podocyte-secreted ANGPTL4 binds to and activates integrin-β1 on 8 the podocytes themselves, thereby inducing apoptosis and actin cytoskeletal derangement in 9 an autocrine or paracrine manner. To test this hypothesis, we performed a 10 coimmunoprecipitation (co-IP) experiment. ANGPTL4 and integrin-β1 formed a complex in 11 podocytes, indicating that ANGPTL4 binds to integrin-β1 ( Fig. 3B ). Next, we knocked down 12
integrin-β1 in differentiated human podocytes by lentivirus-mediated shRNA interference. 13 Western blotting analyses confirmed the effectiveness of knockdown by the integrin-β1 14 shRNA ( Fig. 3K ). Next, podocytes were incubated under HG conditions (30 mM), or treated 15 with recombinant ANGPTL4 and lentivirus expressing shRNA against integrin-β1 (shβ1), for 16 48 h. ANGPTL4 significantly increased p-FAK expression and induced apoptosis, as 17 indicated by decreased BCL2 and BCL-xl levels and an increased cleaved caspase-3 level 18 (Fig. 3C ). However, ANGPTL4-induced apoptosis under HG conditions was significantly 19 attenuated by shβ1, as was ANGPTL4-induced cytoskeletal derangement ( Fig. 3I-3J ). These 20 data suggest that ANGPTL4 induces podocyte apoptosis and cytoskeletal derangement via the 21 integrin-β1/FAK pathway under HG conditions. 22 23
3
.4. Effects of ManNAc on Biochemical and Physical Parameters 24 25
Because podocyte-secreted hyposialylated ANGPTL4 induces proteinuria, and 26 conversion of hyposialylated ANGPTL4 into its sialylated form reduces proteinuria in 27 NPHS2-ANGPTL4 transgenic rats (Clement et al., 2011), we investigated whether a lack of 28 sialylation is involved in the pathogenesis of proteinuria in DN. We investigated the 29 renoprotective effects of ManNAc against DN in db/db mice in vivo and in HG-induced 30 podocytes in vitro. The diabetic db/db mice displayed marked increases in body weight, 31 fasting plasma glucose levels, and UACR compared to non-diabetic WT mice ( Fig.4A-4C) . 32 There were no significant differences in body weight or fasting plasma glucose level between 33 db/db mice treated or not with ManNAc until 8 weeks. Next, we examined the pathologic features associated with DN in glomeruli ( Fig.  39 4D-4G). The glomerular level of FN, a key pathologic indicator, was significantly higher in 40 diabetic db/db mice than in non-diabetic WT mice. Compared to diabetic db/db mice, 41 ManNAc-treated diabetic mice had significantly lower FN levels ( Fig. 4F-4G ), and 42 significantly less expansion of the glomerular extracellular matrix (Fig. 4D-4E Thickening of the GBM and effacement of foot processes are the major early 47 ultrastructural changes in DN. Next, we investigated podocyte structure and number in 48 diabetic mice (Fig. 5 ). Compared to non-diabetic WT mice, diabetic db/db mice had fewer 49 podocytes per glomerulus, greater GBM thickness, and showed effacement of podocyte foot 50 processes, none of which were noted in ManNAc-treated diabetic mice. Western blotting analyses (Fig. 6 ) revealed significantly increased levels of 55 phospho-FAK and phospho-AKT in glomerulus lysates from diabetic db/db mice, suggesting 1 hyperglycemia-induced integrin signaling in the kidney. ManNAc reduced the expression 2 levels of phospho-FAK and phospho-AKT. Moreover, the activation of caspases, as indicated 3
by an increased level of cleaved caspase-3, was observed in db/db mice. Interestingly, 4
ManNAc inhibited the activation of caspase-3 in glomerulus lysates from diabetic db/db mice. 5 These data suggested that ManNAc has potential as a novel therapeutic for DN. Podocytes incubated under HG conditions for 48 h had high levels of integrin-related 10 proteins (phospho-AKT and phospho-FAK) and showed apoptosis, as indicated by decreased 11 levels of BCL2 and BCL-xl and an increased level of cleaved caspase-3. These effects were 12 abrogated by ManNAc ( Fig. 7A-7F) . Moreover, the ANGPTL4-induced cytoskeletal 13 derangement in podocytes was significantly attenuated by ManNAc( Fig. 7G-7H ). 14 15
4. Discussion 16 17 We found that the expression of ANGPTL4 in glomeruli from the renal cortex was 18 significantly increased in diabetic rats. Moreover, it induced podocyte apoptosis and actin 19 cytoskeleton derangement via the integrin pathway under HG conditions. In addition, these 20
were attenuated by blocking ANGPTL4 and integrin-β1 using a neutralizing antibody and 21 lentivirus in vitro. Finally, the ANGPTL4-induced damage to podocytes may be due to 22 increased secretion of hyposialylated ANGPTL4 by podocytes under HG conditions and was 23 attenuated by conversion of hyposialylated ANGPTL4 into its sialylated form in vivo and in 24 vitro. 25 Integrins are a family of cell surface adhesion and signaling molecules consisting of an ANGPTL4-induced apoptosis of podocytes was attenuated by blocking integrin-β1 in vitro, 47 this may be due to β1 integrin was not completely knocked out, but its overexpression under 48 high glucose conditions was knock down to reduce high glucose-induced increase in podocyte 49 apoptosis. 50 Our data suggest that glycemic control is important for preventing ANGPTL4-induced 51 loss of podocytes in early-stage DN. We found that ANGPTL4 induced apoptosis of 52 podocytes under HG conditions via the integrin pathway. Furthermore, ANGPTL4-induced 53 apoptosis of podocytes was attenuated by blocking integrin-β1 in vitro. The 54
hyperglycemia-induced expression of integrin receptors in DN could render podocytes more 55 susceptible to ANGPTL4, leading to the induction of apoptosis via the ANGPTL4/integrin 1 signaling pathway. 2 Derangement of the actin cytoskeletal complex also has been demonstrated to play a 3 critical role in foot process effacement (Faul, Asanuma, Yanagida-Asanuma et al., 2007). 4 Following damage to podocytes, cytoskeletal reorganization results in foot process 5 effacement. The highly ordered parallel contractile actin filament bundles in the foot 6 processes become disordered, shortened, and branched under pathological conditions, 7 resulting in proteinuria(Schell, Baumhakl, Salou et al., 2013). We demonstrated that 8 ANGPTL4 alters podocyte morphology by activating integrinβ1 under HG conditions. 9
The mechanism underlying the ANGPTL4-induced actin cytoskeleton derangement in 10 podocytes is important. We found that FAK, an integrin-signaling protein, is activated in 11 podocytes under hyperglycemic conditions and following the application of ANGPTL4. 12 Activation of FAK initiates focal adhesion derangement, resulting in retraction of the foot 13 processes and reduced stress fiber formation and effacement. inhibited FAK activation in diabetic mice. 28 In vitro, incubation of human podocytes with the sialic acid precursor ManNAc reduced 29 apoptosis and suppressed the activation of integrin signaling and the resulting cytoskeletal 30 reorganization under HG conditions. ManNAc can be absorbed into cells, which can improve 31 high glucose-induced podocyte apoptosis and damage to the cytoskeleton. Although the 32 precise mechanism is unclear, the process is rapid and efficient and thought to involve 33 non-clathrin mediated mechanisms, largely amiloride sensitive fluid phase pinocytosis(Bardor, 34 Nguyen, Diaz et al., 2005).These in vivo and in vitro results indicate that ANGPTL4-mediated 35 podocyte injury may be caused by increased secretion of hyposialylated ANGPTL4 by 36 podocytes. 37 38 5. Conclusion 39 40 In conclusion, the increased ANGPTL4 expression under HG conditions resulted in 41 damage to podocytes. ANGPTL4 induced podocyte apoptosis and actin cytoskeletal 42 derangement via the integrin/FAK pathway under HG conditions. The ANGPTL4-induced 43 apoptosis of podocytes was attenuated by blocking integrin-β1. These effects of ANGPTL4 44 may be due to increased secretion of hyposialylated ANGPTL4 by podocytes in DN. 45 Therefore, sialylation-based strategies have potential for treating common forms of 46 proteinuric Conflict of interests 6 7
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Fig. 2 Increased ANGPTL4 expression is associated with a hyperglycemia-induced

Fig. 3. ANGPTL4 induces apoptosis of podocytes and actin cytoskeleton derangement
Evidence supports ANGPTL4 played an important role in the pathogenesis of DN.
Increased ANGPTL4 expression is associated with a hyperglycemia Induced podocytes apoptosis and actin cytoskeleton derangement.
ANGPTL4 induced podocytes apoptosis and actin cytoskeletal derangement via the integrinβ1/FAK pathway under high glucose.
Sialic acid precursor N-acetylmannosamine (ManNAc) has renoprotective effects against DN.
Increased podocyte-secreted hyposialylated ANGPTL4 may involved in HG-induced podocyte apoptosis and cytoskeletal derangement in diabetic nephropathy.
